Clinical Trial VICCGI1156
Research use of human biospecimens from colorectal cancer patients and clinical testing for the assignment of therapy
- Protocol No. VICCGI1156
- Open Date: 02/03/2012
- Staging: NA
- Age Group: Adults
- Scope: Local
- Objective: The purpose of this research is to identify biological characteristics occurring in the initiation and progression of colorectal cancer. This information should enhance our understanding of the biology and aid colorectal patients and their treating physician in future treatment approaches.
- Disease Sites: Colon; Rectal
- Therapies: None Specified
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- Secondary Protocol No: Not Specified
Patients are being asked to take part in this research study because they have colorectal cancer. The purpose of this study is to look at genes (DNA) and how they affect health and disease. Genes are the instruction manual for the body. The genes patients get from their parents decide what they look like and how their body behaves. They can also tell us a person-s risk for certain diseases and how they will respond to treatment. These tests may provide information about the patient's tumor that could help them make treatment plans in the future. If any tissue remains after this testing is done, patients can choose to have this remaining tissue used for medical research. Almost all of the genes to be tested are only in the tumor and are not found in normal tissue. These markers are not usually passed within families from one generation to another. They also do not tell us about the chance of other family members getting cancer.
Not provided. Please call for more information.